Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine for treatment-resistant depression: randomized placebo-controlled trial
2006-001798-95Phase 2Terminated
- Sponsor
- Jari Tiihonen
- Start
- Mar 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in major depressive disorder (MDD) and bipolar disorder (BD) comparing Ketamine infusion arm with Placebo infusion arm (2 arms). Started Mar 2006; status: terminated.
02
Drugs
ketamine
03
Conditions
major depressive disorder (MDD)bipolar disorder (BD)
Beyond the preview
Go deeper on 2006-001798-95.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001798-95.